Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
12.46
+0.47 (3.92%)
Jul 25, 2025, 3:00 PM CST
SHA:603567 Revenue
Heilongjiang ZBD Pharmaceutical had revenue of 468.94M CNY in the quarter ending March 31, 2025, a decrease of -58.03%. This brings the company's revenue in the last twelve months to 2.06B, down -31.29% year-over-year. In the year 2024, Heilongjiang ZBD Pharmaceutical had annual revenue of 2.70B, down -13.84%.
Revenue (ttm)
2.06B
Revenue Growth
-31.29%
P/S Ratio
5.69
Revenue / Employee
875.09K
Employees
2,349
Market Cap
11.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.70B | -434.25M | -13.84% |
Dec 31, 2023 | 3.14B | -1.08B | -25.53% |
Dec 31, 2022 | 4.21B | 87.33M | 2.12% |
Dec 31, 2021 | 4.13B | 723.07M | 21.24% |
Dec 31, 2020 | 3.40B | 111.89M | 3.40% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |